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1. Introduction 
1.1 Endothelial apoptosis and vascular remodeling 
Atherosclerotic diseases (AD) and immune-mediated vasculopathy of the transplanted 
organ (referred to as transplant vasculopathy (TV)) are both characterized by vessel wall 
thickening and fibrotic changes that lead to progressive vascular obliteration (Al-Lamki et 
al., 2008; Cailhier et al., 2006; Cornell et al., 2008; Mitchell, 2009; Rahmani et al., 2006; 
Valantine, 2003). The endothelium, positioned at the interface of blood flow and the vessel 
wall, serves as a physiological barrier and sensor of environmental stress. The “response to 
injury hypothesis“ proposed by Russell Ross in the 70’s suggested that endothelial injury 
prompts vascular smooth muscle cell (VSMC) migration and proliferation, therefore 
initiating neointima formation (Ross et al., 1977; Ross and Glomset, 1976). Initially, vascular 
remodeling is beneficial but repeated cycles of injury, proliferation and repair lead to 
maladaptive remodeling and lumen narrowing. To date, in vitro and in vivo studies in 
animals and humans confirmed that endothelial apoptosis is a key determinant in the 
development of AD and TV (Rossig et al., 2001). Various immune and non-immune factors, 
such as cytotoxic T-cells, donor-specific antibodies, high cholesterol and hyperglycemia 
account for increased endothelial apoptosis (Cailhier et al., 2006). In turn, migration and 
accumulation of VSMC, surviving and accumulating within a hostile environment through 
acquisition of an anti-apoptotic phenotype, form the initial neointima. Histological and 
biochemical features characterizing AD and TV include 1) extracellular matrix (ECM) 
degradation that likely facilitate VSMC migration; 2) acquisition of a synthetic and anti-
apoptotic phenotype by neointimal cells (VSMC), mesenchymal stem cells (MSC) and 
fibroblasts associated with Bcl-xl overexpression (Gennaro et al., 2004; Hirata et al., 2000; 
Pollman et al., 1998) and 3) differentiation of fibroblasts into myofibroblasts of importance in 
fibrogenic vascular changes (Tomasek et al., 2002) (Figure 1). The molecular interplay 
regulating intercellular communication between apoptotic endothelial cells (EC) and 
neointimal cells are only beginning to be unraveled. 
1.2 Proteomics for studying Post Mortem Signals (PMS) exported by apoptotic EC 
Apoptotic programmed cell death is classically considered a silent process. The first clues 
suggesting that apoptotic endothelial cells may not "go quietly" stems from pharmacological  
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Fig. 1. Schematic diagram of the initiation of vascular remodeling characteristic of AD and 
TV. Immune and non-immune factors induce endothelial apoptosis. Endothelial apoptosis 
precedes neo-intima formation. The latter is accompanied by ECM degradation and 
proliferation and resistance to apoptosis of neo-intimal cells (VSMC, MSC, EPC, fibroblasts 
and myofibroblasts). Homing of MSC and EPC as well as myofibroblast differentiation 
contribute to fibrogenic changes observed with vascular remodeling. 
or genetic approaches aimed at inhibiting endothelial apoptosis in models of AD or TV. 
Inhibition of endothelial apoptosis was shown to block the development of vascular 
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remodeling, suggesting a paracrine role for the apoptotic endothelium in triggering 
pathways of importance in neointima formation (Cailhier et al., 2006; Choy et al., 2004a; 
Choy et al., 2004b; Shimizu et al., 2000a; Shimizu et al., 2000b, 2002a, b). Cell biology 
approaches supported this contention and showed that medium conditioned by apoptotic 
EC regulates the survival and differentiation of major cellular constituents of the vessel wall 
(Cailhier et al., 2006; Laplante et al., 2005; Raymond et al., 2004; Soulez et al., 2010). 
Execution of the apoptotic program relies mainly on post-translational modifications, such 
as protein-protein interactions, protein translocation and proteolysis that will set in motion 
the molecular pathways regulating the various phases of apoptosis (Thiede and Rudel, 
2004;Wang and Chen, 2011; Mahrus et al., 2008). The caspase family of cysteine proteases is 
central to the regulation of the various phases of apoptosis. Their activation in association 
with mitochondrial destabilization or extracellular death receptor activation leads to 
modifications in the architecture of intracellular organelles and fragmentation of the 
cytoskeleton, the ER and the nucleus (Taylor et al., 2008). Apoptosis triggers changes in the 
cell membrane including blebbing and extracellular exposure of PS of importance as a 
phagocyte recognition signal (Leroyer et al., 2008; Martinez et al., 2005; Pober and Sessa, 
2007; Verhoven et al., 1995). In addition, mounting evidence suggests that the apoptotic 
program also regulates the extracellular export of a finely regulated set of signals of 
importance in leukocyte trafficking, phagocytosis and coagulation (Bournazou et al., 2009; 
Lauber et al., 2003; Truman et al., 2008).  
The complete set of mediators released by a cell at a given time, defined as a secretome, 
can be decrypted through high-throughput methods based on mass-spectrometry. Use of 
technology focusing on post-transcriptional events bears special importance in dying cells 
where the various levels of molecular regulation depend on protein degradation, 
translocation and specific protein-protein interactions rather than gene transcription. 
Proteomics was instrumental in characterizing the complex mixture of several secretomes 
composed of both soluble and vesicular mediators including microparticles and exosomes 
(Mathivanan and Simpson, 2009). As illustrated by the following reports, large-scale 
mass-spectrometry also eased the identification of paracrine signals (lipids, proteins and 
microparticles) specifically enriched within the secretome of apoptotic cells. For example, 
apoptotic Burkitt lymphoma cells release lysophosphatidylcholine (LPC) through 
activated caspase-3 dependent mechanisms, which in turn favors recruitment of 
macrophages and clearance of apoptotic bodies (Lauber et al., 2003). Apoptotic MCF7 
epithelial cells secrete lactoferrin as a means of promoting migration of mononuclear 
leukocytes while inhibiting migration of polymorphonuclear leukocytes (Bournazou et al., 
2009). Apoptotic EC shed microparticles with potent immunogenic and pro-coagulant 
abilities (Smalley and Ley, 2008; Smalley et al., 2007). In sum, these proteomic-based 
reports suggested that a paracrine response embedded within the apoptotic program and 
herein referred to as post mortem signals (PMS), controls a finely orchestrated network of 
intercellular communication.  
In the following sections, we will highlight the advantage of different proteomic strategies 
for characterization of PMS released by apoptotic cells. The systematic analysis of the 
secretome of apoptotic EC is central to gain insights into novel mechanisms of intercellular 
communication of importance in TV and AD. Also, the characterization of endothelial 
apoptotic secretome represents a unique opportunity to identify biomarkers of the initial 
stage of vascular remodeling. 
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2. Studying the secretome of apoptotic EC: Methodological aspects 
2.1 In vitro experimental systems aimed at studying endothelial apoptosis 
Two major pathways, the intrinsic and extrinsic pathways, regulate the initiation of 
apoptosis. The intrinsic pathway is activated by metabolic disturbances, such as nutrient 
deprivation and oxidative stress, leading to mitochondrial permeabilization, release of 
cytochrome C and activation of caspase-9. The extrinsic pathway is activated by death 
receptors that, upon ligand-mediated activation, recruit an initiator caspase (ex. caspase-
8). The effector phase of apoptosis responsible for cleavage of key substrates that bring 
about the morphological changes of apoptosis is controlled by a common phase regulated 
by effector caspases (-3, -6, -7) (Taylor et al., 2008). Serum starvation (SS) is a classical 
inducer of the intrinsic apoptotic pathway in EC and offers several advantages for the 
characterization of an apoptotic secretome. First, four hours of SS in cultured EC induces 
sequentially mitochondrial permeabilization, activation of caspases -9 and -3, PARP 
cleavage and chromatin condensation characteristic of apoptotic cell death. The functional 
importance of caspase activation in SS-induced apoptosis was validated with caspase 
inhibitors (the pan-caspase inhibitor (ZVAD-FMK) and caspase-3 inhibitor (DEVD-FMK)) 
as well as small interfering RNA (siRNA) targeting caspase-3 (Sirois et al., 2011). Second, 
apoptosis induced by brief SS does not induce necrotic features and cell membrane 
permeabilization, as assessed by fluorescence microscopy with propidium iodide and 
evaluation of lactacte dehydrogenase (LDH) activity in medium conditioned by serum-
starved EC (Laplante et al., 2010; Sirois et al., 2011). The absence of necrosis in this system 
is an asset for studying secretory events in absence of uncontrolled leakage secondary to 
cell membrane damage. Finally, SS circumvents contamination of the secretome by 
residual components of culture medium (such as albumin) that could interfere with the 
identification of less abundant proteins specifically released by apoptotic EC downstream 
of caspase activation.  
2.2 Identification of endothelial PMS by multidimensional proteomics 
A comparative and multidimensional proteomic analysis was undertaken to characterize the 
secretome of apoptotic EC (Sirois et al., 2011) (Figure 2). Proteins specifically released by 
apoptotic EC were identified through comparison of the secretomes generated by equal 
numbers of serum-starved apoptotic EC (SSC-apo) and serum-starved EC in which 
apoptosis was blocked by the irreversible pan-caspase inhibitor ZVAD-fmk (SSC-no-apo). 
Cell media were cleared of cell debris and apoptotic blebs prior to proteomic analysis 
(Cailhier et al., 2008; Laplante et al., 2010; Sirois et al., 2011; Soulez et al., 2010). An 
equivalent amount of proteins were fractionated either by SDS-PAGE or by HPLC anion 
exchange chromatography followed by protein identification by MS/MS (Pshezhetsky et al., 
2007). The two comparative strategies were complemented by a functional approach aimed 
at identifying proteins with an anti-apoptotic activity on VSMC, therefore recapitulating 
induction of the neointimal anti-apoptotic phenotype (Raymond et al., 2004). Proteins 
present in SSC-apo were fractionated by ultrafiltration followed by ion-exchange FPLC. 
Eluted fractions were individually tested in vitro for their ability to inhibit apoptosis of 
VSMC and the fraction displaying a significant anti-apoptotic activity was further 
fractionated by SDS-PAGE followed by protein identification by LC-MS/MS. 
Computational analysis of the peptides identified by mass-spectrometry generated three 
lists built by the functional and the two semi-quantitative comparative approaches.  
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Fig. 2. Schematic representation of the experimental strategy for generating serum-free 
media (conditioned by equal EC numbers in equal volumes of serum-free media for 4 hours) 
by apoptotic (SSC-Apo) and non-apoptotic EC (SSC-No-Apo). Secretomes were collected 
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and depleted of cell debris and apoptotic blebs prior to fractionation. Multidimensional 
proteomics of the secretomes was performed using one functional and two comparative 
approaches. SSC-apo was fractionated by FPLC and each eluted fraction was tested for its 
anti-apoptotic activity in serum-starved VSMC. The fraction with the most significant 
activity was further separated by SDS-PAGE followed by silver staining and in-gel trypsin 
digestion. SSC-apo and SSC-no-apo proteins were also compared and fractionated by HPLC 
or SDS-PAGE prior to protein identification by mass-spectrometry analysis. Identification of 
specific components of the SSC-apo was achieved using stringent selection criteria. To be 
considered a specific component of the apoptotic secretome, the protein had to meet the 
following criteria: protein present in SSC-apo only; protein identified by 2 out of the 3 
proteomic approaches; protein of human origin. 27 proteins were identified and classified 
according to their mode of secretion and the presence of signal peptide, generating novel 
hypotheses that were further validated by cell biology methods. 
3. The caspase-specific endothelial secretome 
A targeted screening strategy was developed to focus on the proteins with the highest 
likelihood of representing caspase-specific secretome components of importance in vascular 
remodeling. 1300 proteins were identified by LC- MS/MS analysis, 2385 were detected by 
SDS-PAGE-MS/MS and 28 proteins were identified by the functional approach. To be 
considered a specific component of the secretome of apoptotic EC, identified proteins had to 
meet concomitantly the following criteria: 1) they had to be identified by at least 2 out of the 
3 different MS/MS approaches, 2) they had to be found exclusively in SSC-Apo, and 3) they 
had to be of human origin. According to these criteria, 27 proteins were classified as specific 
components of endothelial apoptotic secretome  (Table 1) (Sirois et al., 2011). In the 
following section we will describe some of the observed changes and discuss the potential 
function of this apoptotic secretome. 
3.1 Enrichment of proteins associated with non-classical modes of secretion 
Most proteins that are directed to the cell surface or the extracellular space through a 
conventional secretory pathway contain a signal peptide (Nickel and Rabouille, 2009). 
Recent evidence suggests alternative modes of secretion for leaderless proteins, i.e. proteins 
without a signal peptide (Schotman et al., 2008) (Nickel and Rabouille, 2009). To define the 
contribution of classical and non-classical secretory pathways during apoptotic cell death, 
the 27 specific constituents of the endothelial apoptotic secretome were classified according 
to the presence of a signal peptide in their primary amino acid sequence, their mode of 
secretion, and their intracellular distribution (Table 1). This analysis showed that 25 out of 
the 27 proteins appeared to be associated with non-classical modes of secretion, based on 
recent literature and/or the absence of a secretion signal. 13 out of the 27 proteins were 
previously identified as a component of exosomal nanovesicles. Reevaluation of the 
comparative and functional proteomic results identified ten additional exosomal proteins in 
SSC-apo only, whereas only two exosomal proteins were identified in SSC-no-apo (Sirois et 
al., 2011). Finally, 4 proteins (Table 1 group 2) were annotated as potential components of 
exosome-like nanovesicles in other cell types. In total, 31 proteins associated with exosome-
like nanovesicles were considered to be specific components of the secretome of apoptotic 
EC. 
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Abbreviations: Mem: Membranne; V.E.: endocytic pathway including endosomes, MVB and lysosomes; 
C: cytoplasmic; N: nuclear, Ext.:  Identified in the extracellular milieu; N.D.: information non available; 
Mito: mitochondria; WPBs: Weibel Palade Bodies;  **: shedding; Sec. Gran. : Secretory granules 
Table 1. Specific components of the apoptotic secretome (SSC-apo) regrouping 27 mediators 
selected according to stringent criteria (see Figure 2 and the text). Proteins were listed 
according to their mode of secretion, the presence of a signal peptide and their intracellular 
localization. Classical type of secretion was defined as a protein containing a signal peptide 
with secretion mechanism described in the literature. Non-classical type of secretion was 
defined by the absence of a signal peptide or by reports describing their non-classical secretion.  
www.intechopen.com
 
Proteomics – Human Diseases and Protein Functions 
 
282 
Initially characterized by Rose Johnstone in the 80’s, exosomes are now recognized as 
important intercellular carrier devices detected in most biological liquids including plasma 
and urine as well as in the media of cultured mammalian cells (Mathivanan et al., 2010; Pan 
and Johnstone, 1983; Pan et al., 1985). These nanovesicles with a diameter ranging for 50-100 
nm are generated from inward budding of multivesicular bodies (MVB). Exosomes contain 
proteins of the MVB machinery including TSG101 and Alix, both considered classical exosome 
markers (Keller et al., 2006; Thery et al., 2002). Exosomes express MHC class I and II associated 
proteins and play important role in the innate immune system and in antigen presentation 
(Thery et al., 2009). They also contain different cargos including proteins, lipids, microRNAs 
and mRNA (Valadi et al., 2007). Their extracellular release stems from the fusion of MVB with 
the cell membrane but the molecular regulation of MVB exocytosis remains ill defined. A wide 
diversity of cell types have been shown to secrete exosomes but their protein composition 
appears to be cell specific and/or dependent on the metabolic state of the cell.  
Guided by the proteomic results, we hypothesized that apoptotic cells release nanovesicle-
associated mediators and that this process was triggered by caspase activation. This 
hypothesis was further validated by several biochemical techniques, cell biology approaches 
and electron microscopy (Sirois et al., 2011). Apoptotic nanovesicles were shown to express 
classical constituents of exosomes. Electron microscopy with morphometry analysis 
demonstrated that secreted nanovesicles are structurally and functionally distinct from 
apoptotic bodies and represent a novel entity of potential significance in vascular remodeling.  
3.1.1 Nanovesicular PMS as novel anti-apoptotic factors exported by apoptotic EC 
Translationally Controlled Tumour Protein (TCTP) was identified by both functional and 
comparative proteomics in SSC-apo (Table 1, group 1). TCTP is an evolutionarily conserved 
protein of crucial importance during development (Chen et al., 2007) and for intracellular 
inhibition of apoptosis (Telerman and Amson, 2009). TCTP does not contain a secretion 
peptide signal and its extracellular export depends on the exosomal pathway (Amzallag et 
al., 2004; Lespagnol et al., 2008). Using electron microscopy in association with immunogold 
labeling we showed that TCTP was present on the outer surface of endothelial apoptotic 
nanovesicles (Sirois et al., 2011). Caspase-activated apoptotic VSMC and fibroblasts also 
released TCTP-positive nanovesicles in association with apoptosis, suggesting that this 
pathway is active in various cellular components of the vessel wall. TCTP was found to play 
a central role in the activation of an anti-apoptotic phenotype in neointimal cells. VSMC 
exposed to TCTP(+) apoptotic nanovesicles mounted a robust anti-apoptotic response 
whereas VSMC exposed to nanovesicles generated by TCTP-silenced EC failed to develop 
an anti-apoptotic phenotype. Collectively these results suggest that TCTP released by 
apoptotic nanovesicles is a novel and central inducer of resistance to apoptosis in VSMC and 
a biomarker of apoptotic endothelial nanovesicles. 
3.2 PMS characterized as biological mediators of vascular remodeling 
We further addressed the relevance of the secretome released by apoptotic EC in vascular 
remodeling. Since development of AD and TV depends initially on ECM degradation and 
phenotypical changes within neointimal cells (i.e. anti-apoptotic and fibrogenic), the list of 
proteins generated by the multidimensional proteomic strategy was screened for the 
presence of mediators sharing these biological functions. Functional studies on EC, VSMC, 
MSC and fibroblasts highlighted a multifunctional and biochemically complex paracrine 
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activity of the endothelial apoptotic secretome (Cailhier et al., 2008; Laplante et al., 2006; 
Raymond et al., 2004; Raymond et al., 2002; Sirois et al., 2011; Soulez et al., 2010).  
3.2.1 Anti-apoptotic PMS 
The importance of ECM proteolysis in association with endothelial apoptosis was 
highlighted by the identification of the C-terminal perlecan fragment referred to as LG3 by 
MS/MS and validated by western blot analysis (Raymond et al., 2004). This fragment 
induces a significant anti-apoptotic activity on MSC through alpha-integrin-dependent 
activation of the ERK1-2 pathway leading to Bcl-xl overexpression (Soulez et al., 2010). LG3 
also interacts with beta-integrins on fibroblasts to induce an anti-apoptotic response but the 
intermediate signaling component differs (Laplante et al., 2006). LG3–integrin interactions in 
fibroblasts leads to sequential activation of Src family kinases with downstream 
phosphatidylinositol 3-kinase (PI3K)-dependent induction of Bcl-xl (Laplante et al., 2006). In 
support of a functionally important role for LG3 in TV, increased LG3 urinary levels were 
reported in renal allograft recipients with chronic rejection (Goligorsky et al., 2007).  
Comparative and functional proteomics of media conditioned by apoptotic and non-apoptotic 
EC also revealed the presence of proteases, including ADAM17, ADMTS4, SPUVE, tPA and 
cathepsin L of potential importance in ECM proteolysis (Cailhier et al., 2008). The extracellular 
export of cathepsin L, which was validated by WB analysis and functional studies, was found 
to occur through caspase-3 dependent pathways and to play a central role in cleavage of 
perlecan and generation of the bioactive LG3 anti-apoptotic fragment (Cailhier et al., 2008). 
Apoptotic EC export a complex array of soluble and vesicular transport-assisted mediators 
sharing a common anti-apoptotic activity. Interestingly, these mediators target differentially 
the cellular components of the vascular wall through non-redundant signaling mechanisms, 
adding specificity to the secreted signals.  
3.2.2 Fibrogenic PMS 
Vascular remodeling is associated with fibrogenic changes characterized by the accumulation 
of myofibroblasts within the vessel wall. Myofibroblasts represent a differentiated and 
activated subset of fibroblasts characterized by de novo expression of contractile stress fibers 
and alpha-smooth-muscle actin (α-SMA) and enhanced production of collagen I and II. The 
accumulation of myofibroblasts plays an important role in myointimal thickening and 
vascular stiffness characteristic of AD and TV. The fibrogenic mediator Connective Tissue 
Growth Factor (CTGF) was identified with an abundance ratio of 2.5 in medium conditioned 
by apoptotic EC as compared with medium conditioned by non-apoptotic EC (Laplante et al., 
2010). Western blotting confirmed that caspase activation significantly increased the release of 
CTGF by EC during apoptosis. The central importance of CTGF in the fibrogenic response 
triggered by the endothelial secretome was highlighted by injecting mice sub-cutaneously with 
medium conditioned by apoptotic or non-apoptotic EC. A significant fibrogenic response with 
increased skin thickness and enhanced production of collagen I developed in mice injected 
with medium conditioned by apoptotic EC. Also, CTGF immunodepletion abrogated the 
fibrogenic activity of medium conditioned by apoptotic EC.  
3.2.3 PMS with potential biological activity on vascular repair 
Besides PMS characterized and described above, other components of the secretome 
released by apoptotic EC are potential regulators of vascular remodeling. PLA2G2D was 
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enriched in the secretome of apoptotic EC (Table 1, Group 1) and recent evidence suggests 
that it could participate in vascular remodeling. PLA2G2D belongs to a family of secreted 
phospholipases (sPLA2), which catalyze hydrolysis of membrane glycerophospholipids to 
release fatty acids and lysophospholipids (Murakami et al., 2010). PLA2G2D secreted 
through the exosomal pathway favors intercellular transfer of inflammatory molecules, 
including prostaglandins (Subra et al., 2010). Tissue plasminogen activator (tPA) was also 
identified in the secretome of apoptotic EC (Table 1, Group 4) (Cailhier et al., 2008). Recent 
studies suggest that extracellular release of tPA fosters the development of fibrogenic 
changes (Edgtton et al., 2004; Hu et al., 2008b; Zhang et al., 2007). Convincing evidence also 
suggests a predominant role for tPA in atherosclerotic diseases (Gramling and Church, 
2010). In fibroblasts and myofibroblasts, tPA favors myofibroblast differentiation and 
induces anti-apoptotic phenotypes through phosphorylation of Bad and the inhibition of the 
intrinsic apoptotic pathway (Hu et al., 2008a). 
4. Conclusion 
Characterizing secretomes released by apoptotic cells implies inherent experimental 
challenges. Cell death is regulated by post-transcriptional events based on protein 
translocation and cleavage. Failure to take into consideration the importance of proteolysis, 
protein translocation and activation of non-classical secretion pathways during apoptosis 
will undermine the experimental strategy. The type of initiating apoptotic signal and the 
phase of apoptosis to be studied should also guide the design of the proteomic strategy. 
Creative data mining based on a combination of technical and functional criteria is 
necessary to gain novel insights into the modes of intercellular communication associated 
with cell death. The use of a multidimensional proteomics was instrumental in 
characterizing the importance of caspase activation as a novel regulator of non-classical 
modes of secretion. It allowed us to demonstrate that apoptotic cells release apoptotic 
nanovesicles, a novel type of membrane vesicle distinct from apoptotic bodies and 
reminiscent of exosomes. Mediators of importance in vascular remodeling and of potential 
use as biomarkers of endothelial injury, such as TCTP, LG3, CTGF, cathepsin L, EGF, 
PLA2GD2 and tPA were also identified. Further analysis of the complex secretome of 
apoptotic cells, including biochemical and functional characterization of apoptotic blebs and 
nanovesicles, should provide further insights into the mechanisms of intercellular 
communication between dying cells and the local microenvironment.  
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